🔎 Trials Near Me

Dachaigh › Aillse Blaodaire Neo-invasive › Pennsylvania › Pittsburgh

Sgrùdaidhean clionaigeach Aillse Blaodaire Neo-invasive ann an Pittsburgh, PA

Tha 4 sgrùdaidhean airson Aillse Blaodaire Neo-invasive a’ lorg phàirtichean aig làraichean ann agus timcheall air Pittsburgh (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

A’ fastadhÌre 3
  • University Of Pittsburgh Medical Center UPMC Hillman Cancer Center, Pittsburgh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06919965

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

A’ fastadhSgrùdadh amharc
  • MidLantic Urology - Haverford Road - Bryn Mawr, Bryn Mawr · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07309445

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

A’ fastadhÌre 2
  • University of Pittsburgh Medical Center, Pittsburgh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

A’ fastadhÌre 1
  • Allegheny General Hospital, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT05614739

Sgrùdaidhean Aillse Blaodaire Neo-invasive ann am bailtean eile

Sgrùdaidhean eile ann an Pittsburgh

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.